Global Cannabinoids, a bulk and wholesale B2B manufacturer and distributor of hemp-derived cannabinoids and finished products, is set to merge with EXMceuticals, an emerging bio-sciences company specializing in the production of unique cannabinoid formulations. GC will own c. 66% of EXM's issued and outstanding shares and existing EXM shareholders will hold c. 33% of EXM's issued and outstanding shares on a proforma basis. Financial terms were not disclosed. "The team at EXM shares the same vision for the future as we do. GC's commitment to quality, consistency and best in class pricing, combined with EXM's global reach, will allow for rapid expansion to customers in emerging markets. We are excited for the opportunities ahead," Kelly Ann Lewis-Bortman, GC's Chief Executive Officer.